Senti Bio adjourns annual shareholder meeting to Oct. 15 to solicit merger votes
Senti Biosciences adjourned its virtual 2026 annual shareholder meeting without conducting business. Meeting pause aimed to allow more time to solicit votes supporting the merger agreement proposal outlined in the Sept. 24 proxy statement. Session will reconvene Oct. 15, 2026 at 8:00 a.m. Pacific time; quorum was present. Proposals remain unchanged; polls stay open; record date remains Sept. 23, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065685), on October 13, 2026, and is solely responsible for the information contained therein. (C)
Senti Biosciences adjourned its virtual 2026 annual shareholder meeting without conducting business. Meeting pause aimed to allow more time to solicit votes supporting the merger agreement proposal outlined in the Sept. 24 proxy statement. Session will reconvene Oct.
m. Pacific time; quorum was present. Proposals remain unchanged; polls stay open; record date remains Sept. 23, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Holdings Inc. S.
Securities and Exchange Commission (Ref. ID: 0001628280-26-065685), on October 13, 2026, and is solely responsible for the information contained therein. (C)